Journal Menu► ▼ Journal Menu
Journal Browser► ▼ Journal Browser
Special Issue "Nanoparticles for Targeting and Treating Macrophages"
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Biologics and Biosimilars".
Deadline for manuscript submissions: closed (31 March 2023) | Viewed by 4156
Special Issue Editor
2. August Pi i Sunyer Biomedical Research Institute (IDIBAPS), 08036 Barcelona, Spain
3. Institute for Medical Engineering and Science, MIT, Cambridge, MA 02139, USA
Interests: nanoparticles; macrophages; liver; regeneration; fibrosis; inflammation
Special Issue Information
Nanoparticles are nanomaterials with three external nanoscale dimensions with tunable physical, chemical, and biological characteristics. Regardless of the nanomaterial composition, macrophages can detect and incorporate these foreign bodies by phagocytosis. Recent investigations are taking advantage of this biological fact to design nanoparticles for specific macrophage targeting and treatment in a wide array of diseases. Macrophages are plastic cells from the innate immune system that play different roles in the development, homeostasis, tissue repair and immune response. Indeed, macrophage modulation is of vital importance in chronic inflammation, fibrosis, wound healing, and cancer. Nanoparticles can be modified by the addition of ligands to achieve specific macrophage targeting for drug or gene therapy. They can also be integrated in hydrogels or medical devices to attract and modulate macrophages and the innate immune response. The aim of this issue is to uncover all the different strategies to use nanoparticles to target and modulate macrophages.
As the Guest Editor of the Pharmaceutics Special Issue entitled “Nanoparticles for Targeting and Treating Macrophages”, I would like to cordially invite you to contribute with a research article or a review paper to this Issue due to your excellent contributions to this field. This Special Issue aims to uncover all the different strategies to use nanoparticles to target and treat macrophages.
In this Special Issue, original research articles and reviews are welcome. Research areas may include (but not limited to) the following: Nanoscale colloidal systems, nanomaterials, hydrogels, or devices incorporating nanoparticles designed to target and treat macrophages.
I look forward to receiving your contributions.
Dr. Pedro Melgar-Lesmes
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- wound healing